Lakers’ surprise 10-day signing: Kobe Bufkin gets the call as LeBron’s sons stay in focus
14 January 2026
1 min read

Lakers’ surprise 10-day signing: Kobe Bufkin gets the call as LeBron’s sons stay in focus

Los Angeles, January 13, 2026, 22:30 PST

Key points

  • The Los Angeles Lakers signed guard Kobe Bufkin to a 10-day contract on Tuesday.
  • Bufkin has been producing for the South Bay Lakers, Los Angeles’ NBA G League affiliate.
  • The short-term deal comes with Los Angeles squeezed by NBA salary-cap rules.

The Los Angeles Lakers signed guard Kobe Bufkin to a 10-day contract on Tuesday, the team announced. 1

The move matters because a 10-day contract is the shortest standard NBA deal, and it signals how tight the Lakers’ roster options are right now. Hoops Rumors reported the contract will pay Bufkin $131,970 and carry the same cap hit for Los Angeles, which is operating at its first-apron hard cap — a payroll ceiling teams cannot cross once triggered under the NBA’s latest labor deal. 2

Shams Charania of ESPN reported earlier that the Lakers had agreed to the deal, noting Bufkin’s strong play for South Bay and a brief stint with Memphis this season. 3

Bufkin, 22, was the No. 15 overall pick in the 2023 draft and played college basketball at Michigan. He is listed as a guard on the Lakers’ roster on NBA.com. 4

Coach JJ Redick told reporters Bufkin has “shown he can be engaged and guard” with South Bay, adding that the newcomer may not play immediately but will get a chance over the 10-day window. 5

Bufkin’s deal is also a small piece of larger midseason churn for Los Angeles, which has leaned on its G League pipeline for depth while it navigates cap limits and a compressed schedule. Hoops Rumors said the Lakers were already projected to have limited flexibility for a longer signing later this month.

But a 10-day contract cuts both ways. Bufkin may not crack the rotation, and his recent track record includes limited NBA minutes and a season in which he did not appear during a previous 10-day opportunity, according to Hoops Rumors’ report.

The signing lands in a Lakers spotlight that is not just about roster math. Bronny James remains on the team alongside his father LeBron James, after signing a four-year rookie contract worth $7.9 million that ESPN previously reported included a team option in the fourth season. 6

Off the court, a Times of India report published Wednesday put the combined net worth of Bronny and his younger brother Bryce at about $11.3 million, citing estimates from Forbes and On3. The report also said Bronny’s endorsements included deals with brands such as Nike and Beats, while Bryce’s earnings were tied to NIL contracts. 7

Bryce James is listed as a freshman guard on Arizona’s 2025-26 roster, according to the university’s athletics site. 8

Stock Market Today

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

7 February 2026
Home Depot shares rose 0.7% to $385.15 Friday, trading between $379.10 and $386.37. Investors await a delayed U.S. jobs report Wednesday and CPI data Friday, both postponed by a brief government shutdown. Home Depot reports fourth-quarter earnings Feb. 24. The Dow closed above 50,000 for the first time.
JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

7 February 2026
JPMorgan shares rose 3.95% to $322.40 Friday, outpacing other major banks as U.S. stocks rallied and the Dow closed above 50,000 for the first time. The bank recently completed a $3 billion subordinated notes offering. Investors are watching for delayed U.S. jobs data and inflation figures next week, ahead of JPMorgan’s Feb. 23 company update.
AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

7 February 2026
AbbVie shares rose 2% to $223.43 Friday, capping a volatile week marked by earnings and drug sales scrutiny. Moody’s upgraded AbbVie’s credit rating to A2, citing strong performance in immunology and neuroscience. Investors remain focused on Skyrizi and Rinvoq growth amid rising competition and recent regulatory filings. Trading volume stayed below average, with the stock still 9% off its 52-week high.
SK hynix stock price slips into Monday after S&P upgrade, tech selloff

SK hynix stock price slips into Monday after S&P upgrade, tech selloff

7 February 2026
SK hynix shares closed at 839,000 won, down 0.36% Friday and 8% for the week, as tech stocks retreated across Asia. S&P Global Ratings upgraded the chipmaker to “BBB+” with a positive outlook, citing strong HBM sales. The KOSPI fell 1.4% Friday, ending a six-week winning streak. Traders await Monday’s Seoul open for signs of further tech weakness.
South32 Ltd stock freezes at A$3.96 — what investors watch before its next update
Previous Story

South32 Ltd stock freezes at A$3.96 — what investors watch before its next update

UOB stock price today: U11 edges higher as investors line up for Feb earnings
Next Story

UOB stock price today: U11 edges higher as investors line up for Feb earnings

Go toTop